Livmor, a digital health solutions company, provides a patient-engaging remote monitoring system for critical physiological biomarkers.
HeartBeam said in a news release that the acquisition extends its reach in remote monitoring and detection. It now has full ownership of Livmor’s Halo AFib detection system. Livmor received FDA 510(k) clearance for the Halo wearable AFib detection system in October 2020.
The Halo system provides continuous monitoring of pulse rhythms to detect AFib on-demand during the day and automatically overnight.
HeartBeam and Livmor partnered last month to build a HeartBeam-branded version of the Halo cloud-based software platform. This collaboration allowed HeartBeam to meet its schedule for FDA submission of its AIMI s…